Toxicological evaluation of sediment samples spiked with human pharmaceutical products: Energy status and neuroendocrine effects in marine polychaetes Hediste diversicolor

Ecotoxicology and Environmental Safety

Volumn 118, Issue , 2015, Pages 27-36

  Maranho, L A ^a   Andre C ^b   DelValls, T A ^a   Gagne F ^b   Martin Diaz M L ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b ENVIRONMENT CANADA   (Canada)

Author keywords

Energy status; Hediste diversicolor; Inflammation; Marine sediment; Neuroendocrine effects; Pharmaceutical compounds

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CARBAMAZEPINE; ETHINYLESTRADIOL; FLUOXETINE; IBUPROFEN; LIPID; MONOAMINE; PROPRANOLOL; PROSTAGLANDIN SYNTHASE; BIOLOGICAL MARKER; DRUG; WATER POLLUTANT;

BENTHOS; BIOTA; DRUG; ECOTOXICOLOGY; MARINE SEDIMENT; PHYSIOLOGICAL RESPONSE; POLYCHAETE; SEDIMENT POLLUTION;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BENTHOS; CELL ENERGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ECOTOXICOLOGY; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT ASSESSMENT; ENZYME ACTIVITY; ENZYME INHIBITION; HEDISTE DIVERSICOLOR; INFLAMMATION; MARINE ENVIRONMENT; MITOCHONDRIAL ENERGY TRANSFER; MONOAMINE METABOLISM; NEUROENDOCRINOLOGY; NONHUMAN; POLYCHAETA; SEDIMENT; TOXICITY TESTING; ANIMAL; CHEMISTRY; DRUG EFFECTS; ELECTRON TRANSPORT; IMMUNOLOGY; LIPID METABOLISM; METABOLISM; MITOCHONDRION; NEUROSECRETION; TOXICITY; WATER POLLUTANT;

HEDISTE DIVERSICOLOR; POLYCHAETA;

ANIMALS; BIOMARKERS; ELECTRON TRANSPORT; ENERGY METABOLISM; GEOLOGIC SEDIMENTS; LIPID METABOLISM; MITOCHONDRIA; MONOAMINE OXIDASE; NEUROSECRETORY SYSTEMS; PHARMACEUTICAL PREPARATIONS; POLYCHAETA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; WATER POLLUTANTS, CHEMICAL;

EID: 84927926846     PISSN: 01476513     EISSN: 10902414     Source Type: Journal    
DOI: 10.1016/j.ecoenv.2015.04.010     Document Type: Article

References (86)

1. Aguirre-Martínez G.V., Del Valls T.A., Martín-Díaz M.L. Identification of biomarkers responsive to chronic exposure to pharmaceuticals in target tissues of Carcinus maenas. Mar. Environ. Res. 2013, 87-88:1-11.
2. Aguirre-Martínez G.V., Del Valls T.A., Martín-Díaz M.L. Early responses measured in the brachyuran crab Carcinus maenas exposed to carbamazepine and novobiocin: application of a 2-tier approach. Ecotoxicol. Environ. Saf. 2013, 97:47-58.
3. Ayatollahi M., Kholasehzadeh G. Blood glucose and lipids profile in non-diabetic patients taking. Biomed. Res. India 2013, 24(2):193-196.
4. American Society for Testing and Materials (ASTM), 2000. Standard guide for collection, storage, characterization, and manipulation of sediments for toxicological testing. E1391-94. In: Annual Book of ASTM Standards, Vol. 11.05, West Conshohocken, PA.
5. American Society for Testing and Materials (ASTM), 2009. Standard guide for conducting sediment toxicity test with polychaetous annelids. Method E 1611-00. ASTM Annual Book of Standards, Vol. 11.06.
6. Andreozzi R., Marotta R., Pinto G., Pollio A. Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Res. 2002, 36(11):2869-2877.
7. Andreozzi R., Raffaele M., Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50(10):1319-1330.
8. Banta G.T., Andersen O. Bioturbation and the fate of sediment pollutants. Experimental case studies of selected infauna species. Vie Milieu 2003, 53:233-248.
9. Basallote M.D., Rodríguez-Romero A., Blasco J., DelValls T.A., Riba I. Lethal effects on different marine organisms, associated with sediment-seawater acidification deriving from CO2 leakage. Environ. Sci. Pollut. Res. Int. 2012, 19:2550-2560.
10. Bazinet R.P., Rao J.S., Chang L., Rapoport S.I., Lee H.J. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol. Psychiatry 2006, 59(5):401-407.
11. Beausse J. Selected drugs in solid matrices: a review of environmental determination, occurrence and properties of principal substances. Trends Anal. Chem. 2004, 23(10-11):753-761.
12. Beliaeff B., Burgeot T. Integrated biomarker response: a useful tool for ecological risk assessment. Environ. Toxicol. Chem. 2002, 21:1316-1322.
13. Blaise C., Gagné F., Gillis P.L., Eullafroy P. Polychaetes as bioindicators of water quality in the Saguenay Fjord (Quebec, Canada): a preliminary investigation. J. Xenobiot. 2013, 3:1-2.
14. Boxall A.B.A., Ericson J.F. Environmental fate of human pharmaceuticals. Human Pharmaceuticals in the Environment: Current and Future Perspectives 2012, 63-84. Springer. B. Brooks, D. Huggett (Eds.).
15. Bradford M.B. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
16. Branco-de-Almeida L.S., Franco G.C.N., Castro M.L., Santos J.G., Anbinder A.L., Cortelli S.C., Kajiya M., Kawai T., Rosalen P.L. Fluoxetine inhibits inflammatory response and bone loss in a rat model of ligature-induced periodontitis. J. Periodontol. 2012, 83(5):664-671.
17. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slaterry M., La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 2003, 142(3):169-183.
18. Brown D.W., Ketter T.A., Crumlish J., Post R.M. Carbamazepine-induced increase in total serum cholesterol: clinical and theoretical implications. J. Clin. Psychopharmacol. 1992, 12:431-437.
19. Chen Y., McMillan-Ward E., Kong J., Israels S.J., Gibson S.B. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J. Cell Sci. 2007, 120(Pt 23):4155-4166.
20. Crane M., Watts C., Boucard T. Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci. Total Environ. 2006, 367:23-41.
21. Dabhi J.K., Solanki J.K., Mehta A. Antiatherosclerotic activity of ibuprofen, a non-selective COX inhibitor-an animal study. Indian J. Exp. Biol. 2008, 46(6):476-481.
22. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107(6):907-938.
23. Daughton C.G. Pharmaceuticals in the environment: overarching issues and overview. Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues 2001, 791:2-38. American Chemical Society, Washington, D.C, Symposium Series.
24. De Orte M.R., Lombardi A.T., Sarmiento A.M., Basallote M.D., Rodríguez-Romero A., Riba I., Del Valls T.A. Metal mobility and toxicity to microalgae associated with acidification of sediments: CO2 and acid comparison. Mar. Environ. Res. 2013, 96:136-144.
25. Demircioğlu S., Soylu A., Dirik E. Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children. Pediat. Neurol. 2000, 23(2):142-146.
26. Dubois R.N., Abramson S.B., Crofford L., Gupta Ra, Simon L.S., Van De Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J.[U+202F]: Off. Publ. Fed. Am. Soc. Exp. Biol. 1998, 12(12):1063-1073.
27. Durou C., Poirier L., Amiard J.C., Budzinski H., Gnassia-Barelli M., Lemenach K., Peluhet L., Mouneyrac C., Amiard-Triquet C. Biomonitoring in a clean and a multi-contaminated estuary based on biomarkers and chemical analyses in the endobenthic worm Nereis diversicolor. Environ. Pollut. 2007, 148(2):445-458.
28. Eades C., Waring C.P. The effects of diclofenac oh the physiology of the green shore crab Carcinus maenas. Aquat. Toxicol. 2010, 69:46-48.
29. Eirís J., Novo-Rodríguez M.I., Del Río M., Meseguer P., Del Río M.C., Castro-Gago M. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res. 2000, 41(1):1-7.
30. Farré M.L., Ferrer I., Ginebreda A., Figueras M., Olivella L., Tirapu L., Vilanova M. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J. Chromatogr. A 2001, 938(1-2):187-197.
31. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
32. Francis P.C., Birge W.J., Black J.A. Effects of cadmium-enriched sediment on fish and amphibian embryo-larval stages. Ecotoxicol. Environ. Saf. 1984, 8:378-387.
33. Frings C.S., Fendley T.W., Dunn R.T., Queen C.A. Improved determination of total serum lipids by the sulfo-phosphovanillin reaction. Clin. Chem. 1972, 18:673-674.
34. Fujimoto Y., Sakuma S., Inoue T., Uno E., Fujita T. The endocrine disruptor nonylphenol preferentially blocks cyclooxygenase- 1. Life Sci. 2002, 70:2209-2214.
35. Gagné F., Burgeot T., Hellou J., St-Jean S., Farcy E., Blaise C. Spatial variations in biomarkers of Mytilus edulis mussels at four polluted regions spanning the Northern Hemisphere. Environ. Res. 2008, 107(2):201-217.
36. Gagné F., André C., Cejka P., Gagnon C., Blaise C. Toxicological effects of primary-treated urban wastewaters, before and after ozone treatment, on freshwater mussels (Elliptio complanata). Comp. Biochem. Physiol. C 2007, 145:542-552.
37. Gagné F., Blaise C., André C., Gagnon C., Salazar M. Neuroendocrine disruption and health effects in Elliptio complanata mussels exposed to aeration lagoons for wastewater treatment. Chemosphere 2007, 68(4):731-743.
38. Gagné F., Blaise C., André C., Salazar M. Effects of pharmaceutical products and municipal wastewaters on temperature-dependent mitochondrial electron transport activity in Elliptio complanata mussels. Biochemistry 2006, 143(Part C):388-393.
39. Gagné F., Bérubé E., Fournier M., Blaise C. Inflammatory properties of municipal effluents to Elliptio complanata mussels--lack of effects from anti-inflammatory drugs. Comp. Biochem. Phys. Toxicol. Pharmacol. 2005, 141(4):332-337.
40. Galloway T.S., Lewis C., Dolciotti I., Johnston B.D., Moger J., Regoli F. Sublethal toxicity of nano-titanium dioxide and carbon nanotubes in a sediment dwelling marine polychaete. Environ. Pollut. 2010, 158:1748-1755.
41. Gomes T., Gonzalez-Rey M., Rodríguez-Romero A., Trombini C., Riba I., Blasco J., Bebianno M.J. Biomarkers in Nereis diversicolor (Polychaeta: Nereididae) as management tools for environmental assessment on the southwest Iberian coast. Sci. Mar. 2013, 77(S1):69-78.
42. Guerlet E., Vasseur P., Giambérini L. Spatial and temporal variations of bio- logical responses to environmental pollution in the freshwater zebra mussel. Ecotoxicol. Environ. Saf. 2010, 73:1170-2118.
43. Guler Y., Ford A.T. Anti-depressants make amphipods see the light. Aquat. Toxicol. 2010, 99(3):397-404.
44. Hernando M.D., Mezcua M., Fernández-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69(2):334-342.
45. Isojärvi J.I.T., Pakarinen J.A., Myllylä V.V. Serum lipid levels during carbamazepine medication: a prospective study. Arch. Neurol. 1993, 50(6):590-593.
46. Jelic A., Petrovic M., Barceló D. Multi-residue method for trace level determination of pharmaceuticals in solid samples using pressurized liquid extraction followed by liquid chromatography/ quadrupole-linear ion trap mass spectrometry. Talanta 2009, 80:363-371.
47. Kalman J., Buffet P.E., Amiard J.C., Denis F., Mouneyrac C., Amiard-Triquet C. Assessment of the influence of confounding factors (weight, salinity) on the response of biomarkers in the estuarine polychaete Nereis diversicolor. Biomarkers 2010, 15(5):461-469.
48. King F., Packard T.T. Respiration and the activity of the respiratory electron transport system in marine zooplankton. Limnol. Oceanogr. 1975, 20:849-854.
49. Kuo C., Chen Y., Fan H., Chuang H., Hsieh S. enhancement of vitellogenin synthesis by serotonin in the giant freshwater prawn Macrobrachium rosenbergii (de Man). Zool. Stud. 2009, 48(5):597-606.
50. Kwon J.W., Armbrust K.L. Aqueous solubility, n-octanol-water partition coefficient, and sorption of five selective serotonin reuptake inhibitors to sediments and soils. Bull. Environ. Contam. Toxicol. 2008, 81(2):128-135.
51. Lam M.W., Young C.J., Brain R.A., Johnson D.J., Hanson M.A., Wilson C.J., Richard S.M., Solomon K.R., Mabury S.A. Aquatic persistence of eight pharmaceuticals in a microcosm study. Environ. Toxicol. Chem. 2004, 23(6):1431-1440.
52. Lewis C., Galloway T. Genotoxic damage in polychaetes: a study of species and cell-type sensitivities. Mutat. Res. 2008, 654(1):69-75.
53. Lewis C., Watson G.J. Expanding the ecotoxicological toolbox: the inclusion of polychaete reproductive endpoints. Mar. Environ. Res. 2012, 75:10-22.
54. Lin A.Y.C., Lin C.A., Tung H.H., Chary N.S. Potential for biodegradation and sorption of acetaminophen, caffeine, propranolol and acebutolol in lab-scale aqueous environments. J. Hazard. Mater. 2010, 183(1-3):242-250.
55. Löffler D., Römbke J., Meller M., Ternes T.A. Environmental fate of pharmaceuticals in water/sediment systems. Environ. Sci. Technol. 2005, 39(14):5209-5218.
56. Maia H., Casoy J., Athayde C., Valente Filho J., Coutinho E.M. The effect of a continuous regimen of drospirenone 3mg/ethinylestradiol 30 microg on Cox-2 and Ki-67 expression in the endometrium. J. Eur. Soc. Contracept. Reprod. Health Care 2010, 15(1):35-40.
57. Maranho L.A., Baena-Nogueras R.M., Lara-Martín P.A., DelValls T.A., Martín-Díaz M.L. Bioavailability, oxidative stress, neurotoxicity and genotoxicity of pharmaceuticals bound to marine sediments. The use of the polychaete Hediste diversicolor as bioindicator species. Environ. Res. 2014, 134:353-365.
58. Matsutani T., Nomura T. In vitro effects of serotonin and prostaglandins on release of eggs from the ovary of the scallop, Patinopecten yessoensis. Gen. Comp. Endocrinol. 1987, 67:111-118.
59. Mes T., De, Zeeman G., Lettinga G. Occurrence and fate of estrone, 17β-estradiol and 17α-ethynylestradiol in STPs for domestic wastewater. Rev. Environ. Sci. Biotechnol. 2005, 4:275-311.
60. Metcalfe C.D., Miao X.S., Koenig B.G., Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ. Toxicol. Chem. 2003, 22:2881-2889.
61. Nagpal N.K. Meays,C.L., 2009. Water quality guidelines for pharmaceutically-active-compounds (PhACs): 17alpha-ethinylestradiol (EE2). Technical Appendix. Ministry of Environment Province of British Columbia p. 27.
62. Palace V.P., Evans R.E., Wautier K., Baron C.L., Werner J., Klaverkamp J.F., Kidd K.A., Dick T.A. Altered distribution of lipid-soluble antioxidant vitamins in juvenile sturgeon exposed to waterborne ethynylestradiol. Environ. Toxicol. Chem. 2001, 20(10):2370-2376.
63. Pérez E., Blasco J., Solé M. Biomarker responses to pollution in two invertebrate species: Scrobicularia plana and Nereis diversicolor from the Cádiz bay (SW Spain). Mar. Environ. Res. 2004, 58(2-5):275-279.
64. Pintado-Herrera M.G., González-Mazo E., Lara-Martín P.A. Environmentally friendly analysis of emerging contaminants by pressurized hot water extraction-stir bar sorptive extraction-derivatization and gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 2013, 405(1):401-411.
65. Prisco M., Valiante S., Maddalena M.D.F., Raucci F., Del Giudice G., Romano M., Laforgia V., Limatola E., Piero A. Effect of 17beta-estradiol and progesterone on vitellogenesis in the spotted ray Torpedo marmorata Risso 1810 (Elasmobranchii: Torpediniformes): studies on females and on estrogen-treated males. Gen. Comp. Endocrinol. 2008, 157(2):125-132.
66. OECD, 2000. Adsorption-desorption using a batch equilibrium method Guideline p. 106.
67. OECD, 2004. Sediment - Water Chironomid toxicity test using spiked sediment Guideline p. 218.
68. Quinn B., Gagné F., Blaise C. . An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian Hydra attenuate. Sci. Total Environ. 2008, 389(2-3):306-314.
69. Quinn B., Gagnè F., Blaise C. . The effects of pharmaceuticals on the regeneration of the cnidarian Hydra attenuata. Sci. Total Environ. 2008, 402:62-69.
70. Santos L.H.M.L.M., Araujo A.N., Fachini A., Pena A., Deleure-Matos C., Montenegro M.C.B.S.M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175:45-95.
71. Schmidt W., O'Rourke K., Hernan R., Quinn B. Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standardized toxicity tests. Mar. Pollut. Bull. 2011, 62(7):1389-1395.
72. Serafim A., Company R., Lopes B., Fonseca V.F., França S., Vasconcelos R.P., Bebianno M.J., Cabral H.N. Application of an integrated biomarker response index (IBR) to assess temporal variation of environmental quality in two Portuguese aquatic systems. Ecol. Indic. 2012, 19:215-225.
73. Sloley B.D. Metabolism of monoamines in invertebrates: the relative importance of monoamine oxidase in different phyla. Neurotoxicology 2004, 25(1-2):175-183.
74. Smolders R., Bervoets L., De Coen W., Blust R. Cellular energy allocation in zebra mussels exposed along a pollution gradient: linking cellular effects to higher levels of biological organization. Environ. Pollut. 2004, 129:99-112.
75. Solé M., Kopecka-Pilarczyk J., Blasco J. Pollution biomarkers in two estuarine invertebrates, Nereis diversicolor and Scrobicularia plana, from a Marsh ecosystem in SW Spain. Environ. Int. 2009, 35(3):523-531.
76. Siwickiia A.K., Studnicka M., Morand M., Pozet F., Terech-Majewska E. Comparative immunotoxicology-a new direction. Acta Vet. Brno 1998, 67:295-301.
77. Schnell S., Bols N.C., Barata C., Porte C. Single and combined toxicity of pharmaceuticals and personal care products (PPCPs) on the rainbow trout liver cell line RTL-W1. Aquat. Toxicol. 2009, 93(4):244-252.
78. Scheytt T., Mersmann P., Lindstädt R., Heberer T. Determination of sorption coefficients of pharmaceutically active substances carbamazepine, diclofenac, and ibuprofen, in sandy sediments. Chemosphere 2005, 60(2):245-253.
79. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., Blazer V.S., Norris D.O., Vajda A.M. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44(6):1918-1925.
80. Ternes T.A., Andersen H., Gilberg D., Bonerz M. Determination of estrogens in sludge and sediments by liquid extraction and GC/MS/MS. Anal. Chem. 2002, 74:3498-3504.
81. Thain J. Bifield,S., 2001. ICES techniques in marine environmental sciences biological effects of contaminants[U+202F]: sediment bioassay using the polychaete Arenicola Marina p. 23.
82. USEPA, United States Environmental Protection Agency, 2001. Method for assessing the chronic toxicity of marine and estuarine sediment-associated contaminants with the amphipod Leptocheirus plumulosus EPA 600/R-01/020 (p. 120).
83. Vasskog T., Berger U., Samuelsen P.J., Kallenborn R., Jensen E. Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway. J. Chromatogr. 2006, 1115:187-195.
84. Voudris K.A., Attilakos A., Katsarou E., Drakatos A., Dimou S., Mastroyianni S., Skardoutsoub A., Prassouli A., Garoufi A. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Epilepsy Res. 2006, 70(2-3):211-217.
85. Yu C.P., Chu K.H. Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA. Chemosphere 2009, 75:1281-1286.
86. Zhou J., Broodbank N. Sediment-water interactions of pharmaceutical residues in the river environment. Water Res. 2014, 48:61-70.